| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
Collection of venous blood by venipuncture |
10,596 |
9,220 |
$120K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,480 |
2,297 |
$91K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,041 |
796 |
$35K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
889 |
836 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,926 |
1,762 |
$20K |
| 80053 |
Comprehensive metabolic panel |
3,566 |
3,235 |
$18K |
| 80061 |
Lipid panel |
2,247 |
2,055 |
$16K |
| 80050 |
General health panel |
429 |
410 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
84 |
83 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,301 |
2,138 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,014 |
785 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
44 |
43 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
87 |
87 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,407 |
1,275 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,696 |
3,327 |
$5K |
| 83655 |
|
443 |
426 |
$5K |
| 81001 |
|
1,279 |
1,133 |
$4K |
| 36416 |
|
1,172 |
972 |
$4K |
| 82607 |
|
536 |
515 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,145 |
1,024 |
$4K |
| 87186 |
|
270 |
240 |
$2K |
| 87081 |
|
538 |
521 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
227 |
212 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
54 |
32 |
$1K |
| 82728 |
|
116 |
109 |
$1K |
| 86803 |
|
155 |
151 |
$901.44 |
| 87077 |
|
129 |
110 |
$827.83 |
| 87480 |
|
66 |
60 |
$780.56 |
| 87510 |
|
64 |
59 |
$737.16 |
| 87660 |
|
65 |
59 |
$737.16 |
| 86140 |
|
420 |
388 |
$562.94 |
| 82043 |
|
368 |
337 |
$545.32 |
| 86780 |
|
135 |
124 |
$465.48 |
| 84439 |
|
447 |
417 |
$459.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
82 |
70 |
$434.94 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
935 |
876 |
$428.21 |
| 85027 |
|
242 |
214 |
$383.52 |
| 82570 |
|
525 |
480 |
$329.49 |
| 85651 |
|
213 |
198 |
$251.52 |
| 84466 |
|
51 |
50 |
$184.70 |
| 83540 |
|
77 |
74 |
$166.79 |
| 85610 |
|
247 |
194 |
$139.96 |
| 85046 |
|
232 |
228 |
$117.44 |
| 82784 |
|
15 |
12 |
$74.07 |
| 81514 |
|
124 |
116 |
$68.80 |
| 87340 |
|
15 |
14 |
$45.91 |
| 86706 |
|
17 |
13 |
$45.40 |
| 87088 |
|
76 |
66 |
$44.58 |
| 87210 |
|
15 |
12 |
$32.41 |